These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20067955)

  • 1. Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction.
    Vergeer M; Brunham LR; Koetsveld J; Kruit JK; Verchere CB; Kastelein JJ; Hayden MR; Stroes ES
    Diabetes Care; 2010 Apr; 33(4):869-74. PubMed ID: 20067955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function mutations in ABCA1 and enhanced β-cell secretory capacity in young adults.
    Rickels MR; Goeser ES; Fuller C; Lord C; Bowler AM; Doliba NM; Hegele RA; Cuchel M
    Diabetes; 2015 Jan; 64(1):193-9. PubMed ID: 25125487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice.
    Kruit JK; Kremer PH; Dai L; Tang R; Ruddle P; de Haan W; Brunham LR; Verchere CB; Hayden MR
    Diabetologia; 2010 Jun; 53(6):1110-9. PubMed ID: 20229095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.
    Brunham LR; Kruit JK; Pape TD; Timmins JM; Reuwer AQ; Vasanji Z; Marsh BJ; Rodrigues B; Johnson JD; Parks JS; Verchere CB; Hayden MR
    Nat Med; 2007 Mar; 13(3):340-7. PubMed ID: 17322896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets.
    Wijesekara N; Zhang LH; Kang MH; Abraham T; Bhattacharjee A; Warnock GL; Verchere CB; Hayden MR
    Diabetes; 2012 Mar; 61(3):653-8. PubMed ID: 22315319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules.
    Kruit JK; Wijesekara N; Fox JE; Dai XQ; Brunham LR; Searle GJ; Morgan GP; Costin AJ; Tang R; Bhattacharjee A; Johnson JD; Light PE; Marsh BJ; Macdonald PE; Verchere CB; Hayden MR
    Diabetes; 2011 Dec; 60(12):3186-96. PubMed ID: 21998401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.
    Koseki M; Matsuyama A; Nakatani K; Inagaki M; Nakaoka H; Kawase R; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Sandoval JC; Ohama T; Nakagawa-Toyama Y; Matsuura F; Nishida M; Ishigami M; Hirano K; Sakane N; Kumon Y; Suehiro T; Nakamura T; Shimomura I; Yamashita S
    J Atheroscler Thromb; 2009 Jun; 16(3):292-6. PubMed ID: 19556721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.
    Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA
    FASEB J; 2019 Jul; 33(7):8479-8489. PubMed ID: 30970222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic ABCA1 expression improves β-cell function and glucose tolerance.
    de Haan W; Karasinska JM; Ruddle P; Hayden MR
    Diabetes; 2014 Dec; 63(12):4076-82. PubMed ID: 25028523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
    Dong T; Lyu J; Imachi H; Kobayashi T; Fukunaga K; Sato S; Ibata T; Yoshimoto T; Yonezaki K; Iwama H; Zhang G; Murao K
    Eur J Pharmacol; 2018 Nov; 838():78-84. PubMed ID: 30201376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of ATP-binding cassette transporter A1 and G1 with insulin secretion in human insulinomas.
    Zhou H; Li C; Li J; Yao H; Su R; Li W; Xu M
    Pancreas; 2012 Aug; 41(6):934-9. PubMed ID: 22466164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145.
    Kang MH; Zhang LH; Wijesekara N; de Haan W; Butland S; Bhattacharjee A; Hayden MR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2724-32. PubMed ID: 24135019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 regulates the expression of the ATP-binding cassette transporter A1 via transcriptional factor PREB in the pancreatic β cell line.
    Miyai Y; Murao K; Imachi H; Li J; Nishiuchi Y; Masugata H; Iwama H; Kushida Y; Ishida T; Haba R
    J Endocrinol Invest; 2011 Oct; 34(9):e268-74. PubMed ID: 21521937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
    Frikke-Schmidt R; Nordestgaard BG; Stene MC; Sethi AA; Remaley AT; Schnohr P; Grande P; Tybjaerg-Hansen A
    JAMA; 2008 Jun; 299(21):2524-32. PubMed ID: 18523221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice.
    Wijesekara N; Kaur A; Westwell-Roper C; Nackiewicz D; Soukhatcheva G; Hayden MR; Verchere CB
    Diabetologia; 2016 Jun; 59(6):1242-6. PubMed ID: 26970755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of TNF-α on the expression of ABCA1 in pancreatic β-cells.
    Sato S; Imachi H; Lyu J; Miyai Y; Fukunaga K; Dong T; Ibata T; Kobayashi T; Yoshimoto T; Kikuchi F; Yonezaki K; Yamaji N; Iwama H; Murao K
    J Mol Endocrinol; 2018 Oct; 61(4):185-193. PubMed ID: 30131353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.
    Bochem AE; van Wijk DF; Holleboom AG; Duivenvoorden R; Motazacker MM; Dallinga-Thie GM; de Groot E; Kastelein JJ; Nederveen AJ; Hovingh GK; Stroes ES
    Eur Heart J; 2013 Jan; 34(4):286-91. PubMed ID: 23136402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.
    van Dam MJ; de Groot E; Clee SM; Hovingh GK; Roelants R; Brooks-Wilson A; Zwinderman AH; Smit AJ; Smelt AH; Groen AK; Hayden MR; Kastelein JJ
    Lancet; 2002 Jan; 359(9300):37-42. PubMed ID: 11809185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism.
    Cochran BJ; Hou L; Manavalan AP; Moore BM; Tabet F; Sultana A; Cuesta Torres L; Tang S; Shrestha S; Senanayake P; Patel M; Ryder WJ; Bongers A; Maraninchi M; Wasinger VC; Westerterp M; Tall AR; Barter PJ; Rye KA
    Diabetes; 2016 Dec; 65(12):3610-3620. PubMed ID: 27702832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.